ApicHope(SZ:300723) Xin Lang Cai Jing·2026-01-16 03:02Group 1 - The stock of Yipinhong Pharmaceutical Group Co., Ltd. fell by 5.22% to 36.83 CNY per share, with a trading volume of 345 million CNY and a turnover rate of 2.18%, resulting in a total market capitalization of 16.636 billion CNY [1] - Yipinhong was established on February 4, 2002, and listed on November 16, 2017. The company is located in Guangzhou, Guangdong Province, and its main business involves the research, production, and sales of proprietary drugs, as well as the sales of agency drugs [1] - The revenue composition of Yipinhong includes 61.12% from pediatric drugs, 22.71% from chronic disease drugs, and 16.17% from other products [1] Group 2 - According to data from the top ten holdings of funds, one fund under Bosera Asset Management holds Yipinhong as a significant investment. The Bosera New Strategy Mixed A Fund (001522) held 17,600 shares in the third quarter, accounting for 1.85% of the fund's net value, ranking as the seventh largest holding [2] - The Bosera New Strategy Mixed A Fund was established on November 23, 2015, with a latest scale of 55.9469 million CNY. Year-to-date returns are 3.44%, ranking 5041 out of 8847 in its category, while the one-year return is 12.24%, ranking 6188 out of 8094 [2] - The fund managers, Li Chongyang and Luo Xiao, have tenures of 2 years and 345 days, and 3 years and 110 days respectively, with total assets under management of 1.106 billion CNY and 18.779 billion CNY respectively [2]